Participants 33 100 4
renal transplant recipients with tacrolimus-based immunosuppression
Participants 371 621 6
study was conducted in 15 centers in France and 1 center in Belgium; 309 patients were randomized to receive either induction therapy with ATG (n=151) followed by initiation of tacrolimus on day 9 or immediate tacrolimus-based triple therapy (n=158).
